このエントリーをはてなブックマークに追加
ID 50823
FullText URL
Thumnail 125_145.pdf 743 KB
Title Alternative
Molecular targeted therapies and gastroenterological neoplasia
Author
Keywords
消化器がん
分子標的薬
化学療法
Note
特集 (Feature Article)
Published Date
2013-08-01
Publication Title
岡山医学会雑誌
Publication Title Alternative
Journal of Okayama Medical Association
Volume
volume125
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
145
End Page
152
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
http://www.okayama-u.ac.jp/user/oma/
References
1) Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR : Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clinical Oncol (2009) 27, 3677-3683.
2) Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, et al. : Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA) : a phase 3, open-label, randomised controlled trial. Lancet (2010) 376, 687-697.
3) Ramucirumab AIDS gastric cancer survival. Cancer discov (2013) 3, OF6.
4) Van Cutsem E, de Haas S, Kang YK, Ohtsu A, Tebbutt NC, Ming Xu J, Peng Yong W, Langer B, Delmar P, Scherer SJ, Shah MA : Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer : a biomarker evaluation from the AVAGAST randomized phase III trial. J Clin Oncol ournal (2012) 30, 2119-2127.
5) Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, et al. : Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 359, 378-390.
6) Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, et al. : Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma : a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol (2009) 10, 25-34.
7) Wacker B, Nagrani T, Weinberg J, Witt K, Clark G, Cagnoni PJ : Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies. Clin Cancer Res (2007) 13, 3913-3921.
8) Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, et al. : Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 364, 514-523.
9) Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, H?rsch D, et al. : Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 364, 501-513.
10) Bennouna J, Sastre J, Arnold D, ?sterlund P, Greil R, Van Cutsem E, von Moos R, Vi?itez JM, Bouch? O, Borg C, Steffens CC, Alonso-Ordu?a V, et al. : Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147) : a randomised phase 3 trial. Lancet Oncol (2013) 14, 29-37.
11) Santini D, Vincenzi B, Addeo R, Garufi C, Masi G, Scartozzi M, Mancuso A, Frezza AM, Venditti O, Imperatori M, Schiavon G, Bronte G, et al. : Cetuximab rechallenge in metastatic colorectal cancer patients : how to come away from acquired resistance? Ann Oncol (2012) 23, 2313-2318.
12) Van Cutsem E, Tabernero J, Lakomy R, Prenen H, Prausov? J, Macarulla T, Ruff P, van Hazel GA, Moiseyenko V, Ferry D, McKendrick J, Polikoff J, et al. : Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol (2012) 30, 3499-3506.
13) Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouch? O, Mineur L, Barone C, Adenis A, Tabernero J, et al. : Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT) : an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet (2013) 381, 303-312.
14) Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, et al. : Cetuximab for the treatment of colorectal cancer. N Engl J Med (2007) 357, 2040-2048.
15) Nishida T, Takahashi T, Miyazaki Y : Gastrointestinal stromal tumor : a bridge between bench and bedside. Gastric Cancer (2009) 12, 175-188.
language
日本語
OAI-PMH Set
岡山大学
Copyright Holders
Copyright (c) 2013 岡山医学会
File Version
publisher
Refereed
True
DOI
Sort Key
9
Eprints Journal Name
joma